Portugal, April 8 -- Portugal based Biocartis NV has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 0539 26 - Pole-Pold1 Mutation Assay Ruo 6Test. The value of the contract is worth 432000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....